article · 2000
Phase II study of cisplatin (CDDP) and 5-fluorouracil (5-FU) with concurrent hyperfractionated thoracic radiotherapy (HFTRT) for locally advanced non-small-cell lung cancer (LA-NSCLC): A preliminary report from the Okayama Lung Cancer Study Group
1 citationsDOI: https://doi.org/10.1016/s0169-5002(00)80385-2